Speakers

Sample of Keynote Speakers and their Case Studies

Quentin Descat

Head Global Cardiovascular – Commercial Launch Brands Lead

CASE STUDY

The Employer Experience Proposition

Global Internal Benchmark for key HR Metrics. Key HR Metrics are aggregated and shared globally between different regions so each region can compare their own results with others within Sony. This is a good use case of how own data is utilised and leveraged in a global scale.

Quentin Descat

Head Global Cardiovascular – Commercial Launch Brands Lead

CASE STUDY

The Employer Experience Proposition

Global Internal Benchmark for key HR Metrics. Key HR Metrics are aggregated and shared globally between different regions so each region can compare their own results with others within Sony. This is a good use case of how own data is utilised and leveraged in a global scale.

Quentin Descat

Head Global Cardiovascular – Commercial Launch Brands Lead

CASE STUDY

The Employer Experience Proposition

Global Internal Benchmark for key HR Metrics. Key HR Metrics are aggregated and shared globally between different regions so each region can compare their own results with others within Sony. This is a good use case of how own data is utilised and leveraged in a global scale.

Слайдшоу

Bettina Wick-Urban

Senior Scientific Director Benefit Risk Management PV & PS

CASE STUDY

Assessment of Benefit-Risk During Clinical Development

Carla Mateo Mohedano

Associate Director, Patient Safety Scientist — Oncology

CASE STUDY

Unravelling the Complexity of Signal Detection and Risk Assessments on the Oncology Therapeutic Area

This presentation aims to emphasise the challenges of signal detection and risk assessments within the Oncology Therapeutic Area. In addition, it provides some useful insights on how to address some of the main challenges in this landscape.

Michael Murphy

AVP, Head of PV Operations

CASE STUDY

Impact/Benefit of Automation and AI on Pharmacovigilance

The main focus in the presentation is on the use of automation in PV and the benefits it can bring. I would also like to go over Change Management with the implementation of automation/AI.

Erika Barbarosie

Associate Director Compliance

CASE STUDY

The Pitfalls of the EU PSMF

Daniela Santos

Head Global Drug
Safety Hub

CASE STUDY

Innovations in Global Drug Safety: A Comprehensive Approach to Risk Management and Pharmacovigilance

Thumbnail 1
Thumbnail 2
Thumbnail 3
Thumbnail 4
Thumbnail 5
11

Bettina Wick-Urban

Senior Scientific Director Benefit Risk Management PV & PS

CASE STUDY

Assessment of Benefit-Risk During Clinical Development

22

Carla Mateo Mohedano

Associate Director, Patient Safety Scientist — Oncology

CASE STUDY

Unravelling the Complexity of Signal Detection and Risk Assessments on the Oncology Therapeutic Area

This presentation aims to emphasise the challenges of signal detection and risk assessments within the Oncology Therapeutic Area. In addition, it provides some useful insights on how to address some of the main challenges in this landscape.

33

Daniela Santos

Head Global Drug
Safety Hub

CASE STUDY

Innovations in Global Drug Safety: A Comprehensive Approach to Risk Management and Pharmacovigilance

44

Erika Barbarosie

Associate Director Compliance

CASE STUDY

The Pitfalls of the EU PSMF

66

Michael Murphy

AVP, Head of PV Operations

CASE STUDY

Impact/Benefit of Automation and AI on Pharmacovigilance

The main focus in the presentation is on the use of automation in PV and the benefits it can bring. I would also like to go over Change Management with the implementation of automation/AI.